ELV
Elevance Health Inc
395.90$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 11.1% | 10.7% | 15.0% | 13.7% | 14.7% | 16.0% | 15.7% | 15.0% | 18.6% | 17.4% | 18.3% | 20.4% | |
| 3.4% | 3.4% | 6.1% | 5.1% | 5.4% | 6.3% | 6.5% | 5.0% | 7.2% | 6.0% | 7.1% | 7.8% | |
| 3.4% | 3.4% | 6.1% | 5.1% | 5.4% | 6.3% | 6.5% | 5.0% | 7.2% | 6.0% | 7.1% | 7.8% | |
| 7.7% | 7.3% | 8.8% | 8.7% | 9.3% | 9.7% | 9.2% | 9.9% | 11.4% | 11.4% | 11.2% | 12.5% | |
| -36.8% | -34.4% | -51.7% | -50.7% | -35.3% | -37.1% | -38.9% | -39.5% | -11.1% | -42.5% | – | – | |
| 3.1% | 3.2% | 3.0% | 3.0% | 3.8% | 4.0% | 3.9% | 4.0% | 4.2% | 4.5% | 4.5% | 3.9% | |
| 27.1% | 27.8% | 26.5% | 26.9% | 28.3% | 26.2% | 24.6% | 24.9% | 23.7% | 23.2% | 24.2% | 23.3% | |
| 12.6% | 12.9% | 12.0% | 11.7% | 12.4% | 11.1% | 10.7% | 10.9% | 10.0% | 9.4% | 10.3% | 9.2% | |
| 61.5% | 63.5% | 62.2% | 62.9% | 60.6% | 59.5% | 62.4% | 62.9% | 64.6% | 63.8% | 64.6% | 63.8% | |
| 12.5% | 12.9% | 13.9% | 14.8% | 13.0% | 14.4% | 13.8% | 15.9% | 18.2% | 17.9% | 16.6% | 16.4% | |
| 1.6% | 0.9% | 2.1% | 3.6% | 2.8% | 3.1% | 0.9% | 2.1% | 1.9% | 1.9% | 1.9% | 1.1% | |
| 10.9% | 12.0% | 11.9% | 11.2% | 10.3% | 11.3% | 12.9% | 13.9% | 15.2% | 14.8% | 13.5% | 14.1% | |
| 22.4% | 24.3% | 21.6% | 24.3% | 23.8% | 22.7% | 21.9% | 21.7% | 21.7% | 21.3% | 25.0% | 25.3% | |
| 38.5% | 36.5% | 37.8% | 37.1% | 39.4% | 40.5% | 37.6% | 37.0% | 35.3% | 36.1% | 35.3% | 36.1% | |
| 22.3% | 23.4% | 24.9% | 25.3% | 27.6% | 28.8% | 27.0% | 27.8% | 28.9% | 29.1% | 28.7% | 29.1% | |
| 0.5% | 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.